Delivery Order SPE2DB24D3013-SPE2DB24FFFUK
Award Date 6/12/24
Potential Completion Date 6/13/24
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,457.60, is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm fixed-price delivery order, with an ultimate completion date of April 8, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,123.75 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,919.15 firm fixed-price delivery order contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication primarily used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,819.13 firm fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,948.02, is for the delivery of VYVANSE 10 MG CAPSULE 100S, a prescription medication used for the treatment of attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,809.68, is a delivery order for the supply of VYVANSE 10 MG CAPSULE 100S, a medication used for the treatment of conditions such as attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 13, 2024 and is a firm fixed-price contract. This award is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 20 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $2,284.28 and a completion date of June 25, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,962.68 firm fixed-price contract is for the supply of VYVANSE 60 MG CAPSULE 100S, a medication used to treat attention deficit hyperactivity disorder (ADHD). The award has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,944.03 contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has a completion date of March 19, 2025 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,302.42 firm fixed-price delivery order is for the supply of VYVANSE 60 MG CAPSULE 100S, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of April 8, 2025 and was awarded on April 7, 2025. This delivery order is part of a larger $999,999,999...